Imugene and City of Hope announce first patient dosed in Phase 1 trial to test cancer-killing oncolytic virus against solid tumors
SYDNEY, Australia and LOS ANGELES — Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company, and City of Hope, one of ...